Worth Venture Partners, LLC Vascular Biogenics Ltd. Call Options Transaction History

Worth Venture Partners, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 13, 2018	SELL	$2.05 - $3.0 $53,504 - $78,300	-26,100 Closed	0 $0
Q1 2018 May 25, 2018	SELL	$2.27 - $8.5 $5.87 Million - $22 Million	-2,583,900 Reduced 99.0%	26,100 $2,000
Q1 2018 May 11, 2018	BUY	$2.27 - $8.5 $5.92 Million - $22.2 Million	2,610,000 New	2,610,000 $2,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.